ESC 365 - Special considerations in the management of patients with AF undergoing ablation or cardioversion.

Open Access

Special considerations in the management of patients with AF undergoing ablation or cardioversion.

Session: Protecting patients through responsible use of novel oral anticoagulants (NOACs)... The right dose for the right patient for stroke prevention

Topic: Atrial fibrillation (AF)

Speaker: Professor S. Hohnloser (Frankfurt, DE)

Sponsored by Bayer AG

Event: ESC Congress 2017

Congress Presentation

About the speaker

Professor Stefan H Hohnloser

Johann Wolfgang Goethe University, Frankfurt (Germany)

30 presentations

1 follower

4 more presentations in this session

Opening remarks - Protecting patients through responsible use of NOACs... The right dose for the right patient for stroke prevention.

Speaker: Professor R. Mehran (New York, US)

New insights on treating patients with atrial fibrillation (AF) who are undergoing percutaneous coronary intervention (PCI) stenting.

Speaker: Professor K. Fox (Edinburgh, GB)

How can we appropriately treat multimorbid patients with AF?

Speaker: Doctor C. Ruff (Boston, US)

Closing remarks - Protecting patients through responsible use of NOACs... The right dose for the right patient for stroke prevention.

Speaker: Doctor R. Cappato (Milan, IT)

Access the full session

Protecting patients through responsible use of novel oral anticoagulants (NOACs)... The right dose for the right patient for stroke prevention

Speakers: Professor S. Hohnloser, Professor R. Mehran, Professor K. Fox, Doctor C. Ruff, Doctor R. Cappato

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by